Xalkori (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the Xalkori drug offered from Pfizer Laboratories Div Pfizer Inc. This Kinase Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Receptor Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 2B6 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Organic Cation Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
| NON-PROPRIETARY NAME: | CRIZOTINIB |
| SUBSTANCE NAME: | CRIZOTINIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Receptor Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 2B6 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Organic Cation Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-08-26 |
| END MARKETING DATE: | 0000-00-00 |
Xalkori HUMAN PRESCRIPTION DRUG Details:
| Item Description | Xalkori from Pfizer Laboratories Div Pfizer Inc |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2011-08-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0069-8140_4cc9d49f-771a-468b-8230-09398cb8cbda |
| PRODUCT NDC: | 0069-8140 |
| APPLICATION NUMBER: | NDA202570 |
Other CRIZOTINIB Pharmaceutical Manufacturers / Labelers:
